Basic Information
| RNALocate ID: | RLID:11001905 |
| RNA Symbol: | hsa-miR-146a-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-146a-5p |
| RNA ID: | miRBase:MIMAT0000449 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001827 | Endoplasmic reticulum membrane | Cortical tissue | 32451872 |
| RLID:01001828 | Mitochondrion | Osteosarcoma cell line (143B) | 27396686 |
| RLID:01001829 | Mitochondrion | Osteosarcoma cell line (143B) | 27563705 |
| RLID:01001830 | Mitochondrion | Human umbilical vein endothelial cells | 30348904 |
| RLID:11001900 | Exosome | Plasma | 19289371 |
| RLID:11001901 | Exosome | Primary dendritic cells | 21505438 |
| RLID:11001902 | Exosome | Renal cancer cells | 21670082 |
| RLID:11001903 | Exosome | Breast milk | 22211110 |
| RLID:11001904 | Exosome | Brain tissue | 23382797 |
| RLID:11001906 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001907 | Exosome | Colon cancer cell line (LIM1863) | 25330373 |
| RLID:11001908 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001909 | Microvesicle | Plasma | 23077538 |
| RLID:11001910 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001911 | Microvesicle | Follicular fluid | 23666971 |
| RLID:11001912 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11000097 | Exosome | Blood|B lymphoblastoid cells|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Tongue tissue | |
| RLID-D:11000377 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-146a-5p | Diffuse large b cell lymphoma | MNDR-E-MI-15282 |
| MNDR | hsa-miR-146a-5p | Splenic marginal zone lymphoma | MNDR-E-MI-15283 |
| MNDR | hsa-miR-146a-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-15284 |
| MNDR | hsa-miR-146a-5p | Oral squamous cell carcinoma | MNDR-E-MI-15285 |
| MNDR | hsa-miR-146a-5p | Medulloblastoma | MNDR-E-MI-15286 |
| MNDR | hsa-miR-146a-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-15287 |
| MNDR | hsa-miR-146a-5p | Lymphoma | MNDR-E-MI-15288 |
| MNDR | hsa-miR-146a-5p | Lymphoma non-hodgkin | MNDR-E-MI-15289 |
| MNDR | hsa-miR-146a-5p | Cutaneous t cell lymphoma | MNDR-E-MI-15290 |
| MNDR | hsa-miR-146a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-15291 |
| MNDR | hsa-miR-146a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-15292 |
| MNDR | hsa-miR-146a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-15293 |
| MNDR | hsa-miR-146a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-15294 |
| MNDR | hsa-miR-146a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-15295 |
| MNDR | hsa-miR-146a-5p | Triple negative breast cancer | MNDR-E-MI-15296 |
| MNDR | hsa-miR-146a-5p | Colitis | MNDR-E-MI-15297 |
| MNDR | hsa-miR-146a-5p | Acute promyelocytic leukemia | MNDR-E-MI-15298 |
| MNDR | hsa-miR-146a-5p | Breast cancer luminal | MNDR-E-MI-15299 |
| MNDR | hsa-miR-146a-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-15300 |
| MNDR | hsa-miR-146a-5p | Anaplastic thyroid carcinoma | MNDR-E-MI-15301 |
| MNDR | hsa-miR-146a-5p | Dermatomyositis | MNDR-E-MI-15302 |
| MNDR | hsa-miR-146a-5p | Castration-resistant prostate cancer | MNDR-E-MI-15303 |
| MNDR | hsa-miR-146a-5p | Hirschsprung disease | MNDR-E-MI-15304 |
| MNDR | hsa-miR-146a-5p | Gastric cancer | MNDR-E-MI-15305 |
| MNDR | hsa-miR-146a-5p | Gastric lymphoma | MNDR-E-MI-15306 |
| MNDR | hsa-miR-146a-5p | Alzheimer disease | MNDR-E-MI-15307 |
| MNDR | hsa-miR-146a-5p | Intracranial aneurysm | MNDR-E-MI-15308 |
| MNDR | hsa-miR-146a-5p | Urinary bladder cancer | MNDR-E-MI-15309 |
| MNDR | hsa-miR-146a-5p | Esophageal carcinoma | MNDR-E-MI-15310 |
| MNDR | hsa-miR-146a-5p | Osteoporosis | MNDR-E-MI-15311 |
| MNDR | hsa-miR-146a-5p | Dysautonomia familial | MNDR-E-MI-15312 |
| MNDR | hsa-miR-146a-5p | Familial hyperlipidemia | MNDR-E-MI-15313 |
| MNDR | hsa-miR-146a-5p | Seizures | MNDR-E-MI-15314 |
| MNDR | hsa-miR-146a-5p | Head and neck cancer | MNDR-E-MI-15315 |
| MNDR | hsa-miR-146a-5p | Creutzfeldt-jakob syndrome | MNDR-E-MI-15316 |
| MNDR | hsa-miR-146a-5p | Dengue disease | MNDR-E-MI-15317 |
| MNDR | hsa-miR-146a-5p | Vogt-koyanagi-harada disease | MNDR-E-MI-15318 |
| MNDR | hsa-miR-146a-5p | Huntington disease | MNDR-E-MI-15319 |
| MNDR | hsa-miR-146a-5p | Chorea | MNDR-E-MI-15320 |
| MNDR | hsa-miR-146a-5p | Cardiovascular disease | MNDR-E-MI-15321 |
| MNDR | hsa-miR-146a-5p | Carotid stenosis | MNDR-E-MI-15322 |
| MNDR | hsa-miR-146a-5p | Moyamoya disease | MNDR-E-MI-15323 |
| MNDR | hsa-miR-146a-5p | Lung cancer | MNDR-E-MI-15324 |
| MNDR | hsa-miR-146a-5p | Giant cell arteritis | MNDR-E-MI-15325 |
| MNDR | hsa-miR-146a-5p | Tuberous sclerosis | MNDR-E-MI-15326 |
| MNDR | hsa-miR-146a-5p | Parkinson disease | MNDR-E-MI-15327 |
| MNDR | hsa-miR-146a-5p | Basal-like breast cancer | MNDR-E-MI-15328 |
| MNDR | hsa-miR-146a-5p | Vascular diseases | MNDR-E-MI-15329 |
| MNDR | hsa-miR-146a-5p | Thyroid cancer | MNDR-E-MI-15330 |
| MNDR | hsa-miR-146a-5p | Pituitary neoplasms | MNDR-E-MI-15331 |
| MNDR | hsa-miR-146a-5p | Pancreatic cancer | MNDR-E-MI-15332 |
| MNDR | hsa-miR-146a-5p | Epilepsy | MNDR-E-MI-15333 |
| MNDR | hsa-miR-146a-5p | Hepatitis C | MNDR-E-MI-15334 |
| MNDR | hsa-miR-146a-5p | Melanoma | MNDR-E-MI-15335 |
| MNDR | hsa-miR-146a-5p | Atherosclerosis | MNDR-E-MI-15336 |
| MNDR | hsa-miR-146a-5p | Rectum adenocarcinoma | MNDR-E-MI-15337 |
| MNDR | hsa-miR-146a-5p | Nephroblastoma | MNDR-E-MI-15338 |
| MNDR | hsa-miR-146a-5p | Colon cancer | MNDR-E-MI-15339 |
| MNDR | hsa-miR-146a-5p | Ischemic attack transient | MNDR-E-MI-15340 |
| MNDR | hsa-miR-146a-5p | Colon adenocarcinoma | MNDR-E-MI-15341 |
| MNDR | hsa-miR-146a-5p | Multiple sclerosis | MNDR-E-MI-15342 |
| MNDR | hsa-miR-146a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-15343 |
| MNDR | hsa-miR-146a-5p | Familial ovarian cancer | MNDR-E-MI-15344 |
| MNDR | hsa-miR-146a-5p | Dermatitis | MNDR-E-MI-15345 |
| MNDR | hsa-miR-146a-5p | Pulmonary tuberculosis | MNDR-E-MI-15346 |
| MNDR | hsa-miR-146a-5p | Glioblastoma | MNDR-E-MI-15347 |
| MNDR | hsa-miR-146a-5p | Astrocytoma | MNDR-E-MI-15348 |
| MNDR | hsa-miR-146a-5p | Glioma | MNDR-E-MI-15349 |
| MNDR | hsa-miR-146a-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-15350 |
| MNDR | hsa-miR-146a-5p | Gastrointestinal system cancer | MNDR-E-MI-15351 |
| MNDR | hsa-miR-146a-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-15352 |
| MNDR | hsa-miR-146a-5p | Epilepsy temporal lobe | MNDR-E-MI-15353 |
| MNDR | hsa-miR-146a-5p | Osteosarcoma | MNDR-E-MI-15354 |
| MNDR | hsa-miR-146a-5p | Inclusion body myositis | MNDR-E-MI-15355 |
| MNDR | hsa-miR-146a-5p | Infarction middle cerebral artery | MNDR-E-MI-15356 |
| MNDR | hsa-miR-146a-5p | Meningioma | MNDR-E-MI-15357 |
| MNDR | hsa-miR-146a-5p | Liver cancer | MNDR-E-MI-15358 |
| MNDR | hsa-miR-146a-5p | Uterine cancer | MNDR-E-MI-15359 |
| MNDR | hsa-miR-146a-5p | Gastric adenocarcinoma | MNDR-E-MI-15360 |
| MNDR | hsa-miR-146a-5p | Cervical squamous cell carcinoma | MNDR-E-MI-15361 |
| MNDR | hsa-miR-146a-5p | Pituitary adenoma | MNDR-E-MI-15362 |
| MNDR | hsa-miR-146a-5p | Lung squamous cell carcinoma | MNDR-E-MI-15363 |
| MNDR | hsa-miR-146a-5p | Carcinoma lung non-small-cell | MNDR-E-MI-15364 |
| MNDR | hsa-miR-146a-5p | Lung adenocarcinoma | MNDR-E-MI-15365 |
| MNDR | hsa-miR-146a-5p | Adrenocortical carcinoma | MNDR-E-MI-15366 |
| MNDR | hsa-miR-146a-5p | Thyroid carcinoma | MNDR-E-MI-15367 |
| MNDR | hsa-miR-146a-5p | Papillary thyroid carcinoma | MNDR-E-MI-15368 |
| MNDR | hsa-miR-146a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-15369 |
| MNDR | hsa-miR-146a-5p | Hypersensitivity reaction type ii disease | MNDR-E-MI-15370 |
| MNDR | hsa-miR-146a-5p | Brain stem cancer | MNDR-E-MI-15371 |
| MNDR | hsa-miR-146a-5p | Coronary restenosis | MNDR-E-MI-15372 |
| MNDR | hsa-miR-146a-5p | Gerstmann-straussler-scheinker disease | MNDR-E-MI-15373 |
| MNDR | hsa-miR-146a-5p | Cervical cancer | MNDR-E-MI-15374 |
| MNDR | hsa-miR-146a-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-15375 |
| MNDR | hsa-miR-146a-5p | Carcinoma renal cell | MNDR-E-MI-15376 |
| MNDR | hsa-miR-146a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-15377 |
| MNDR | hsa-miR-146a-5p | Clear cell renal cell carcinoma | MNDR-E-MI-15378 |
| MNDR | hsa-miR-146a-5p | Biliary tract cancer | MNDR-E-MI-15379 |
| MNDR | hsa-miR-146a-5p | Medulloepithelioma | MNDR-E-MI-15380 |
| MNDR | hsa-miR-146a-5p | Cholangiocarcinoma | MNDR-E-MI-15381 |
| MNDR | hsa-miR-146a-5p | Esophageal cancer | MNDR-E-MI-15382 |
| MNDR | hsa-miR-146a-5p | Scrapie | MNDR-E-MI-15383 |
| MNDR | hsa-miR-146a-5p | T acute lymphoblastic leukemia | MNDR-E-MI-15384 |
| MNDR | hsa-miR-146a-5p | Acute t cell leukemia | MNDR-E-MI-15385 |
| MNDR | hsa-miR-146a-5p | Heart failure | MNDR-E-MI-15386 |
| MNDR | hsa-miR-146a-5p | Fibromyalgia | MNDR-E-MI-15387 |
| MNDR | hsa-miR-146a-5p | Pulmonary hypertension | MNDR-E-MI-15388 |
| MNDR | hsa-miR-146a-5p | Cerebrovascular disease | MNDR-E-MI-15389 |
| MNDR | hsa-miR-146a-5p | Juvenile rheumatoid arthritis | MNDR-E-MI-15390 |
| MNDR | hsa-miR-146a-5p | Hepatocellular carcinoma | MNDR-E-MI-15391 |
| MNDR | hsa-miR-146a-5p | Familiar ovarian carcinoma | MNDR-E-MI-15392 |
| MNDR | hsa-miR-146a-5p | B-cell lymphoma | MNDR-E-MI-15393 |
| MNDR | hsa-miR-146a-5p | Ankylosing spondylitis | MNDR-E-MI-15394 |
| MNDR | hsa-miR-146a-5p | Rheumatoid arthritis | MNDR-E-MI-15395 |
| MNDR | hsa-miR-146a-5p | T-cell leukemia | MNDR-E-MI-15396 |
| MNDR | hsa-miR-146a-5p | Retinoblastoma | MNDR-E-MI-15397 |
| MNDR | hsa-miR-146a-5p | Neuroblastoma | MNDR-E-MI-15398 |
| MNDR | hsa-miR-146a-5p | Chronic fatigue syndrome | MNDR-E-MI-15399 |
| MNDR | hsa-miR-146a-5p | Hodgkin disease | MNDR-E-MI-15400 |
| MNDR | hsa-miR-146a-5p | Ulcerative colitis | MNDR-E-MI-15401 |
| MNDR | hsa-miR-146a-5p | Burkitt lymphoma | MNDR-E-MI-15402 |
| MNDR | hsa-miR-146a-5p | Kaposi sarcoma | MNDR-E-MI-15403 |
| MNDR | hsa-miR-146a-5p | Dementia vascular | MNDR-E-MI-15404 |
| MNDR | hsa-miR-146a-5p | Crohn disease | MNDR-E-MI-15405 |
| MNDR | hsa-miR-146a-5p | Tonsil cancer | MNDR-E-MI-15406 |
| MNDR | hsa-miR-146a-5p | Neuromyelitis optica | MNDR-E-MI-15407 |
| MNDR | hsa-miR-146a-5p | Psoriasis | MNDR-E-MI-15408 |
| MNDR | hsa-miR-146a-5p | Skin cutaneous melanoma | MNDR-E-MI-15409 |
| MNDR | hsa-miR-146a-5p | Skin melanoma | MNDR-E-MI-15410 |
| MNDR | hsa-miR-146a-5p | Subacute sclerosing panencephalitis | MNDR-E-MI-15411 |
| MNDR | hsa-miR-146a-5p | Acute myelocytic leukemia | MNDR-E-MI-15412 |
| MNDR | hsa-miR-146a-5p | Colorectal cancer | MNDR-E-MI-15413 |
| MNDR | hsa-miR-146a-5p | Type 2 diabetes mellitus | MNDR-E-MI-15414 |
| MNDR | hsa-miR-146a-5p | Diabetic neuropathy | MNDR-E-MI-15415 |
| MNDR | hsa-miR-146a-5p | Acute lymphocytic leukemia | MNDR-E-MI-15416 |
| MNDR | hsa-miR-146a-5p | Seizures febrile | MNDR-E-MI-15417 |
| MNDR | hsa-miR-146a-5p | Ependymoma | MNDR-E-MI-15418 |
| MNDR | hsa-miR-146a-5p | Graft vs host disease | MNDR-E-MI-15419 |
| MNDR | hsa-miR-146a-5p | Cardiomegaly | MNDR-E-MI-15420 |
| MNDR | hsa-miR-146a-5p | Nasopharyngeal cancer | MNDR-E-MI-15421 |
| MNDR | hsa-miR-146a-5p | Prostatic neoplasms | MNDR-E-MI-15422 |
| MNDR | hsa-miR-146a-5p | Wounds and injuries | MNDR-E-MI-15423 |
| MNDR | hsa-miR-146a-5p | Muscle weakness | MNDR-E-MI-15424 |
| MNDR | hsa-miR-146a-5p | Epstein-barr virus infections | MNDR-E-MI-15425 |
| MNDR | hsa-miR-146a-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-15426 |
| MNDR | hsa-miR-146a-5p | Gait ataxia | MNDR-E-MI-15427 |
| MNDR | hsa-miR-146a-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-15428 |
| MNDR | hsa-miR-146a-5p | Stroke | MNDR-E-MI-15429 |
| MNDR | hsa-miR-146a-5p | Encephalitis herpes simplex | MNDR-E-MI-15430 |
| MNDR | hsa-miR-146a-5p | Nk/t cell lymphoma | MNDR-E-MI-15431 |
| MNDR | hsa-miR-146a-5p | Stroke lacunar | MNDR-E-MI-15432 |
| MNDR | hsa-miR-146a-5p | Breast cancer her3+ negative | MNDR-E-MI-15433 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABL2 | Homo sapiens | RR00027153 |
TOP